Wlodzimierz A Stanczyk

5PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nonlinear optics and spectroscopyMolecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 19, 2023
Is acriflavine an efficient co-drug in chemotherapy?

Kinga Piorecka, Jan Kurjata, Bartłomiej Gostynski

|May 02, 2022
Reasons for enhanced activity of doxorubicin on co-delivery with octa(3-aminopropyl)silsesquioxane.

Kinga Piorecka, Jan Kurjata, Irena Bak-Sypien

|Sep 10, 2021
Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview.

Kinga Piorecka, Jan Kurjata, Wlodzimierz A Stanczyk

|Dec 30, 2020
Novel Polyhedral Silsesquioxanes [POSS(OH)32] as Anthracycline Nanocarriers-Potential Anticancer Prodrugs.

Kinga Piorecka, Jan Kurjata, Wlodzimierz A Stanczyk

|Dec 08, 2020
Hydrophilic Polyhedral Oligomeric Silsesquioxane, POSS(OH)32, as a Complexing Nanocarrier for Doxorubicin and Daunorubicin.

Kinga Piorecka, Anna Janaszewska, Marta Majkowska

Pageof 1